Skip to main content

Day: November 12, 2024

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) — In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: STIM), please note that in the second paragraph of the “Stockholders Approve Acquisition of Greenbrook TMS” section, it should say that the Company expects to achieve cash flow breakeven by the third quarter of 2025, not the second. The corrected release follows: Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the third quarter of 2024. Third Quarter 2024 HighlightsThird quarter 2024 revenue of $18.5 million, a 4% increase...

Continue reading

Zefiro Methane Corp. Chief Commercial Officer to Serve as Featured Speaker at United Nations COP29

In addition to attending the conference with the Company’s Founder and CEO, Zefiro CCO Tina Reine will be featured as a panelist on a UN COP29 Climate Action Innovation Zone discussion regarding the future of the voluntary carbon marketplace FORT LAUDERDALE, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) — ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced that the Company’s Chief Commercial Officer Tina Reine will serve as a featured speaker at the United Nations’ 2024 Climate Change Conference (“COP29”) tomorrow, November 13th, at 3:40 PM GMT+4 in Baku, Azerbaijan. In addition to attending the conference with Zefiro Founder and Chief Executive Officer Talal Debs, Ms. Reine will lend her expertise to a COP29 Climate Action Innovation Zone-sanctioned panel discussion...

Continue reading

Viridian Metals Announces Opening of Trading on TSX Venture Exchange on November 14, 2024

Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, Nov. 12, 2024 (GLOBE NEWSWIRE) — Viridian Metals Inc. (TSXV:VRDN) (the “Company”) is pleased to provide an update to its press release dated November 6, 2024 in order to confirm that its common shares will open for trading on the TSX Venture Exchange on November 14, 2024 under the ticker symbol “VRDN”. While the Company had initially anticipated trading to commence on or about November 8, there was a technical issue experienced with SEDAR+ which delayed the public release of the Company’s filing statement dated October 28, 2024. The filing statement, as well as all of the material documents relating to the Company’s qualifying transaction are available for consultation under the Company’s SEDAR+ profile. Tyrell...

Continue reading

UPDATE – embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, November 26, 2024. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com. A webcast replay of the call will be available beginning at 11:00 a.m. ET on Nov 26, 2024, via the embecta investor relations website and archived on the website for one year. About embecta embecta is a global diabetes...

Continue reading

Mirasol Resources Closes Private Placement Financing

VANCOUVER, British Columbia, Nov. 12, 2024 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTC: MRZLF) (the “Company” or “Mirasol”) is pleased to announce the closing of the previously announced and upsized non-brokered private placement financing. The Company issued 11,335,132 Units (the “Units”) at a price of $0.45 per Unit for aggregate gross proceeds of $5,100,809.40. (the “Offering”). Each Unit is comprised of one (1) common share and one-half of one (1/2) non-transferable common share purchase warrant (the “Warrant”), with each whole Warrant entitling the holder to purchase one additional common share at a price of $0.60 for a period of twelve (12) months from closing of the Offering.   Proceeds of the Offering will be used to advance exploration, including drilling, at the Company’s flagship Sobek Project in the...

Continue reading

Home BancShares, Inc. to Participate in Fireside Chat at Stephens Annual Investment Conference – (Time Update)

CONWAY, Ark., Nov. 12, 2024 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NYSE: HOMB) (“Home” or “the Company”), and its wholly-owned subsidiary, Centennial Bank (“Centennial”), announced that it would participate in a Fireside Chat during the Stephens Annual Investment Conference being held November 19, 2024. The Company will present at 1:00 p.m. CT (2:00 p.m. ET), on Tuesday, November 19, 2024. The Fireside Chat can be accessed live using the following link: https://wsw.com/webcast/stph35/homb/1819690. A replay will be available from the webcast link for 90 days following the live presentation at the following link: https://wsw.com/webcast/stph35/homb/1819690. Home BancShares, Inc. is a bank holding company, headquartered in Conway, Arkansas. Its wholly-owned subsidiary, Centennial Bank, provides a broad range of commercial and retail...

Continue reading

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma. Presented data supporting RTNova (CLD-400), the company’s systemic antitumor virotherapy platform, at the International Oncolytic Virotherapy Conference (IOVC) in Rotterdam, Netherlands, the Society for Immunotherapy of Cancer (SITC) Annual Meeting, and at Immuno US 2024 in San Diego, California. Raised $2 million in a registered direct offering and concurrent private placement.SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today reported its operating and financial results for the third quarter ended September 30, 2024, and reviewed recent...

Continue reading

Extendicare Announces 2024 Third Quarter Results and Early Redemption of 2025 Debentures

MARKHAM, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2024, and the Company announced that it is exercising its option to redeem all of the outstanding $126.5 million principal amount of 2018-1 5.00% convertible unsecured subordinated debentures (TSX: EXE.DB.C) (the “2025 Debentures”). Third Quarter 2024 HighlightsAdjusted EBITDA(1) excluding out-of-period items increased by $13.5 million or 64.9% to $34.3 million, largely driven by rate increases in long-term care (“LTC”) and home health care and volume growth in home health care and managed services. Home health care average daily volume (“ADV”) grew to 30,181, up 10.2% from Q3 2023. SGP third-party and joint venture serviced beds increased 11.4%...

Continue reading

Tandy Leather Factory Reports Third Quarter 2024 Results

FORT WORTH, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the third fiscal quarter of 2024. Highlights from Third Quarter 2024:Revenues were $17.4 million, down 1.1% from 2023 Operating loss of $0.3 million Net loss of $0.1 million, down from net income of $0.6 million in 2023 Gross margins of 57.8%, down from 62.4% in 2023 Operating expenses $10.3 million, up 2.3% from 2023 Adjusted EBITDA* of $0.2 million Ended quarter with $10.1 million of cash and cash equivalentsTandy Leather Factory’s third quarter sales were $17.4 million in 2024, down from $17.5 million in 2023. Third quarter 2024 gross profit was $10.0 million, down from $10.9 million in 2023. Third quarter saw an operating loss of $0.3 million, down from operating income of $0.9...

Continue reading

Oriental Culture Holding LTD Announces First Half Year of 2024 Unaudited Financial Results

HONG KONG, Nov. 12, 2024 (GLOBE NEWSWIRE) — Oriental Culture Holding LTD. (“OCG” or the “Company”) (NASDAQ: OCG), a leading online provider of collectibles and artwork e-commerce services, today announced its unaudited financial results for the six months ended June 30, 2024. First Half Year of 2024 Financial HighlightsTotal revenues were approximately $0.4 million for the six months ended June 30, 2024, compared with the total revenues of approximately $0.8 million for the six months ended June 30, 2023. Gross profit was approximately $0.3 million for the six months ended June 30, 2024, compared with approximately gross profit of $0.6 million for the six months ended June 30, 2023. Gross margin was 65.8% for the six months ended June 30, 2024, compared with a gross margin of 76.0% for the six months ended June 30, 2023. Loss...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.